Osteogenesis and cytocompatibility compression of cerium and gallium doped mesoporous bioactive glass-ceramics
Source abstract
Abstract
Bone defects have recently become one of the biggest problems for surgeons. This study aims to compression osteogenic properties of cerium and gallium doping in mesoporous bioactive glass-ceramics (MBGCs). MBGCs are synthesized using sol-gel method through evaporation induced self-assembly technique. Small-angle X-ray scattering (SAXS) revealed size of nanoparticle in MBGCs is ∼29 nm. The impact of cerium and gallium ions on ceramics was characterized using Fourier transform infrared (FTIR) and 29Si Magic angle spinning nuclear magnetic resonance (MAS-NMR) spectroscopic methods. Images of samples taken with a transmission electron microscope show aggregated particles with irregular forms. MBGCs doped with cerium and gallium in vitro biocompatibility investigations do not show any cytotoxicity towards MG63 cells and also have considerably improved osteogenic properties. Overall, Ga doped MBGCs with desired osteogenesis properties compared to Ce doped MBGCs, and Ga doped MBGCs offers encouraging possibilities for the effective repair of bone fractures with implants.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics10.1016/j.biomaterials.2011.01.004 ↗
2. Reprint of: review of bioactive glass: from Hench to hybrids10.1016/j.actbio.2015.07.019 ↗
3. Substituted hydroxyapatite coatings of bone implants10.1039/C9TB02710F ↗
4. Third-generation biomedical materials10.1126/science.1067404 ↗
5. Bioceramics: from concept to clinic10.1111/j.1151-2916.1991.tb07132.x ↗
6. Mesoporous bioactive glasses for regenerative medicine
7. Biomaterials against bone infection10.1002/adhm.202000310 ↗
8. Multi-functional silica-based mesoporous materials for simultaneous delivery of biologically active ions and therapeutic biomolecules10.1016/j.actbio.2021.05.007 ↗
9. Bioceramics10.1111/j.1151-2916.1998.tb02540.x ↗
10. Mechanisms of therapeutic activity for gallium10.1016/S0031-6997(24)01383-8 ↗
11. Disruption of murine cardiac allograft acceptance by latent cytomegalovirus10.1111/j.1600-6143.2008.02457.x ↗
12. Potency and cytotoxicity of a novel gallium-containing mesoporous bioactive glass/chitosan composite scaffold as hemostatic agents10.1021/acsami.7b07769 ↗
13. Antimicrobial effect of gallium nitrate against bacteria encountered in burn wound infections10.1039/C7RA10265H ↗
14. Potential of gallium as an antifungal agent10.3389/fcimb.2019.00414 ↗
15. Antibacterial nanocomposite of functionalized nanogold and gallium-doped hydroxyapatite10.1016/j.matlet.2017.01.092 ↗
16. Effect of gallium on the in vitro formation, growth, and solubility of hydroxyapatite10.1007/BF02561406 ↗
17. Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial10.1002/term.2396 ↗
18. Medical applications and toxicities of gallium compounds10.3390/ijerph7052337 ↗
19. Bone particles from gallium- treated rats are resistant to resorption in vivo10.1016/0169-6009(91)90030-4 ↗
20. Gallium inhibits bone resorption by a direct effect onosteoclasts10.1016/0169-6009(90)90106-P ↗
21. The response of pre-osteoblasts and osteoclasts to gallium containing mesoporous bioactive glasses10.1016/j.actbio.2018.06.036 ↗
22. Cerium and gallium containing mesoporous bioactive glass nanoparticles for bone regeneration: bioactivity, biocompatibility and antibacterial activity
23. Antioxidant mesoporous Ce-doped bioactive glass nanoparticles with anti-inflammatory and pro-osteogenic activities
24. Cerium-containing mesoporous bioactive glasses: material characterization, in vitro bioactivity, biocompatibility and cytotoxicity evaluation10.1016/j.micromeso.2018.09.029 ↗
25. Effects of cerium oxide nanoparticles on the proliferation, differentiation, and mineralization function of primary osteoblasts in vitro10.1007/s12011-013-9655-2 ↗
26. Structural and in vitro study of cerium, gallium an zinc containing sol-gel bioactive glasses10.1039/c2jm31767b ↗
27. Substitutions of cerium, gallium and zinc in ordered mesoporous bioactive glasses10.1016/j.actbio.2011.05.033 ↗
28. Cerium-doped bioactive 45S5 glasses: spectroscopic, redox, bioactivity and biocatalytic properties10.1007/s10853-017-0867-2 ↗
29. Cerium (III) and (IV) containing mesoporous glasses/alginate beads for bone regeneration: bioactivity, biocompatibility and reactive oxygen species activity10.1016/j.msec.2019.109971 ↗
30. High-performance mesoporous bioceramics mimicking bone mineralization10.1021/cm800172x ↗
31. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
32. Tailoring the biological response of mesoporous bioactive materials10.1039/C5TB00268K ↗
33. Substitutions of cerium, gallium and zinc in ordered mesoporous bioactive glasses10.1016/j.actbio.2011.05.033 ↗
34. Curcumin release from cerium, gallium and zinc containing mesoporous bioactive glasses10.1016/j.micromeso.2013.06.014 ↗
35. How useful is SBF in predicting in-vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
36. Synthesis and characterization of gelatin-PVP polymer composite scaffold for potential application in bone tissue engineering10.1016/j.eurpolymj.2019.07.007 ↗
37. Controlling growth and osteogenic differentiation of osteoblasts on microgrooved polystyrene surfaces
38. Evaluation of biocompatibility using in-vitro methods: interpretation and limitations
39. In-vitro and in-vivo evaluation of akermanite bioceramics for bone regeneration10.1016/j.biomaterials.2009.05.077 ↗
40. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
41. Determination of size distribution from small-angle scattering data for systems with effective hard-sphere interactions10.1107/S0021889893013810 ↗
42. In vitro antibacterial capacity and cytocompatibility of SiO2 –CaO–P2O5 meso-macroporous glass scaffolds enriched with ZnO10.1039/C4TB00403E ↗
43. Vogel · 1985
44. Nakaumoto · 1997
45. Influence of the stabilization temperature on textural and structural features and ion release in SiO2− CaO− P2O5 sol− gel glasses10.1021/cm011119p ↗
46. Bioactivity of three CaO–P2O5–SiO2 sol-gel glasses10.1002/jbm.10229 ↗
47. Antibacterial properties of poly (octanediol citrate)/gallium-containing bioglass composite scaffolds10.1007/s10856-015-5620-2 ↗
48. Preparation and characterization of bioactive mesoporous wollastonite – polycaprolactone composite scaffold10.1016/j.biomaterials.2008.10.046 ↗
49. Preparation and characterization of bioactive mesoporous calcium silicate–silk fibroin composite films10.1002/jbm.b.31856 ↗
50. Fabrication and characterization of poly (octanediol citrate)/gallium-containing bioglass microcomposite scaffolds10.1007/s10853-014-8782-2 ↗
51. Dexamethasone enhances osteogenic differentiation of bone marrow-and muscle-derived stromal cells and augments ectopic bone formation induced by bone morphogenetic protein-210.1371/journal.pone.0116462 ↗
52. Synergic role of zinc and gallium doping in hydroxyapatite nanoparticles to improve osteogenesis and antibacterial activity10.1016/j.msec.2022.112684 ↗
53. Development of cerium and silicon co-doped hydroxyapatite nanopowder and its in vitro biological studies for bone regeneration applications10.1016/j.apt.2018.07.028 ↗
54. Antioxidant mesoporous Ce-doped bioactive glass nanoparticles with anti-inflammatory and pro-osteogenic activities